Hydroxyzine Pamoate
Product Images NDC 70934-962

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 70934-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 962 30 Master Bottle Label Approval Rev A 03 22)

Label (70934 962 30 Master Bottle Label Approval   Rev A 03 22)
Label for hydroxyzine pamoate capsules, USP 25 mg, containing 30 capsules. The label indicates prescription use only and provides storage instructions to keep the product tightly closed, protect from moisture, and store at 20°-25°C (68°-77°F). The product is labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals.*
FDA Label Image

Chemical Structure (Hypam 01)

Chemical Structure (Hypam 01)
Chemical structure of hydroxyzine pamoate, showing the detailed arrangement of its molecular components including aromatic rings, hydroxyl groups, carboxylic acids, and other functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.